U. McCann - Concepedia

Author

U. McCann

Johns Hopkins University

Also Known As

McCann U., U D McCann, U D. McCann, U MCCANN, U McCann, U. D. MCCANN, U. D. McCann, U. McCann, U.D McCann, U.D. McCann

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University National Institutes of Health National Institute of Mental Health National Institute of Mental Health

About

U. McCann is an author at Johns Hopkins University specializing in medicine, social sciences, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2K
2	Social Sciences	7	7	2.2K
3	Health Sciences	2	2	337
4	Public Health	1	1	34
5	Cognitive Science	1	1	303

U. McCann

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Roland R. Griffiths, William A. Richards, U. McCann, Psychopharmacology PsychiatryMeditationSpiritualityPsychologySocial Sciences	2006	1.6K
Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study U. McCann, Melissa Mertl, Victoria Eligulashvili, Psychopharmacology Substance AbuseCognitive SciencePsychoactive DrugCognitive PerformanceAddiction	1999	303
Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders Anantha Shekhar, U. McCann, Michael J. Meaney, Psychopharmacology Veterinary Behavioral MedicinePsychiatryNational InstituteHuman-animal InteractionAffective Neuroscience	2001	102
Altered neuroendocrine and behavioral responses to m -chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users U. McCann, Melissa Mertl, Dennis L. Murphy, Psychopharmacology Psychoactive DrugBehavioral NeuroscienceAddictionAltered NeuroendocrineBehavioral Pharmacology	1999	85
Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated. U. McCann, George Hatzidimitriou, Alison Ridenour, Journal of Pharmacology and Experimental Therapeutics	1994	85
Implications of Kindling And Quenching For the Possible Frequency Dependence Of rTMS Robert M. Post, Tim A. Kimbrell, Mark A. Frye, CNS Spectrums Synaptic TransmissionNeuromodulation TherapiesAffective NeuroscienceBrain ScienceNeurotransmission	1997	42
Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain Julio Bobes, Pilar A. Sáiz, Teresa Bascarán, European Addiction Research World Health OrganizationSubstance UseMilitary ServicePsychopharmacologyMental Health	2002	34
Effects of the 5-HT3 Antagonist, Ondansetron, on the Behavioral and Physiological Effects of Pentagastrin in Patients with Panic Disorder and Social Phobia U. McCann Neuropsychopharmacology Experimental PsychopathologyPsychiatryBehavioral NeuroscienceMedicineBehavioral Pharmacology	1997	32
What does the dexamethasone suppression test identify? Kousik Krishnan, Randal D. France, Susan Pelton, Biological Psychiatry MedicineDiagnostic TestBioanalysisDiagnostic CriterionDiagnosis	1985	27
Algorithm for the treatment of panic disorder with agoraphobia. Kenneth O. Jobson, Jonathan Davidson, R. Bruce Lydiard, PubMed Experimental PsychopathologyPsychopathologyPsychiatryMedicineClinical Psychology	1995	19

Page 1